{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:42:51Z","timestamp":1790106171283,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-14-01042"],"award-info":[{"award-number":["14-14-01042"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-14-01042-P"],"award-info":[{"award-number":["14-14-01042-P"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["02.522.11.2014"],"award-info":[{"award-number":["02.522.11.2014"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.vaccine.2018.12.067","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T17:28:17Z","timestamp":1547918897000},"page":"1062-1072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection"],"prefix":"10.1016","volume":"37","author":[{"given":"Vladimir A.","family":"Ledov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina E.","family":"Golovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Markina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy A.","family":"Knirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav L.","family":"L'vov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Kovalchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr G.","family":"Aparin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.12.067_b0005","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.12.067_b0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrmicro1662","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"Levine","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2018.12.067_b0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrgastro.2013.12","article-title":"Progress and pitfalls in Shigella vaccine research","volume":"10","author":"Barry","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2018.12.067_b0020","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1093\/clinids\/13.Supplement_4.S279","article-title":"The lipopolysaccharide of Shigella bacteria as a virulence factor","volume":"13","author":"Lindberg","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.067_b0025","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1108472","article-title":"Optimization of virulence functions through glucosylation of Shigella LPS","volume":"307","author":"West","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.12.067_b0030","series-title":"Bacterial Lipopolysaccharides: Structure, Chemical Synthesis, Biogenesis and Interaction with Host Cells","year":"2011"},{"key":"10.1016\/j.vaccine.2018.12.067_b0035","first-page":"39","article-title":"Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification","volume":"216","author":"Rietschel","year":"1996","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2018.12.067_b0040","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum","volume":"171","author":"Robbins","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.067_b0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijmm.2016.03.001","article-title":"Structure and function: Lipid A modifications in commensals and pathogens","volume":"306","author":"Steimle","year":"2016","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.vaccine.2018.12.067_b0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/IAI.00937-10","article-title":"The lipid A phosphate position determines differential host Toll-like receptor 4 responses to phylogenetically related symbiotic and pathogenic bacteria","volume":"79","author":"Coats","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.12.067_b0055","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/647986","article-title":"Tetraacylated lipopolysaccharide of Yersinia pestis can inhibit multiple Toll-like receptor-mediated signaling pathways in human dendritic cells","volume":"200","author":"Telepnev","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.067_b0060","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.4049\/jimmunol.175.7.4669","article-title":"Molecular basis of reduced potency of underacylated endotoxins","volume":"175","author":"Teghanemt","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.12.067_b0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/000163501750266710","article-title":"Porphyromonas gingivalis lipopolysaccharide: an unusual pattern recognition receptor ligand for the innate host defense system","volume":"59","author":"Bainbridge","year":"2001","journal-title":"Acta Odontol Scand"},{"key":"10.1016\/j.vaccine.2018.12.067_b0070","unstructured":"Myers KR, Truchot, AT. U.S. Patent No. 4,912,094. Modified lipopolysaccharides and process of preparation. Washington, DC: US Patent and Trademark Office; 1990."},{"key":"10.1016\/j.vaccine.2018.12.067_b0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1126\/science.3529396","article-title":"Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme","volume":"234","author":"Munford","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.12.067_b0080","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1128\/IAI.69.10.5981-5990.2001","article-title":"Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity","volume":"69","author":"van der Ley","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.12.067_b0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4161\/viru.25965","article-title":"Anti-endotoxin vaccines: back to the future","volume":"5","author":"Cross","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2018.12.067_b0090","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1128\/iai.64.7.2709-2715.1996","article-title":"Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls","volume":"64","author":"Konadu","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.12.067_b0095","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1073\/pnas.0900891106","article-title":"Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates","volume":"106","author":"Robbins","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.12.067_b0100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/cid\/ciu468","article-title":"Shigella isolates from the global enteric multicenter study inform vaccine development","volume":"59","author":"Livio","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.067_b0105","first-page":"83","article-title":"Bacterial lipopolysaccharide-extraction with phenol water and further application of procedure","volume":"1","author":"Westphal","year":"1965","journal-title":"Methods Carbohydr Chem"},{"key":"10.1016\/j.vaccine.2018.12.067_b0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.carres.2009.01.004","article-title":"A similarity in the O-acetylation pattern of the O-antigens of Shigella flexneri types 1a, 1b, and 2a","volume":"344","author":"Perepelov","year":"2009","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2018.12.067_b0115","unstructured":"WHO. Requirements for Vi-polysaccharide typhoid vaccine. Technical Report Series No840. 1994; Annex 1."},{"key":"10.1016\/j.vaccine.2018.12.067_b0120","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.4049\/jimmunol.0901218","article-title":"CD21\/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression","volume":"183","author":"Haas","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.12.067_b0125","first-page":"55","article-title":"A new method for the measurement of protective potency of dysentery vaccines","volume":"9","author":"Sereny","year":"1962","journal-title":"Acta Microbiol Acad Sci Hung"},{"key":"10.1016\/j.vaccine.2018.12.067_b0130","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0142","article-title":"Vaccines against enteric infections for the developing world","volume":"370","author":"Czerkinsky","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2018.12.067_b0135","first-page":"45","article-title":"Shigella lipopolysaccharide: structure, genetics, and vaccine development","volume":"180","author":"Brahmbhatt","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2018.12.067_b0140","series-title":"Microbial toxins","first-page":"309","article-title":"Chemical and biological heterogeneity of endotoxins","author":"Nowotny","year":"1971"},{"key":"10.1016\/j.vaccine.2018.12.067_b0145","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/IAI.67.2.782-788.1999","article-title":"Strategy for cross-protection among Shigella flexneri serotypes","volume":"67","author":"Noriega","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.12.067_b0150","first-page":"60","article-title":"Acute inflammatory response to endotoxin in mice and humans","volume":"12","author":"Copeland","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2018.12.067_b0155","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2174\/092986709788682001","article-title":"The expression of endotoxic activity in the Limulus test as compared to cytokine production in immune cells","volume":"16","author":"Brandenburg","year":"2009","journal-title":"Curr Med Chem"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2018.12.067_b0160","first-page":"III2-8","article-title":"Host-pathogen interactions: the seduction of molecular cross talk","volume":"50","author":"Sansonetti","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2018.12.067_b0165","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/iai.63.1.229-237.1995","article-title":"Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane","volume":"63","author":"Sandlin","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.12.067_b0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1365-3083.2002.01079.x","article-title":"Delayed and reduced adaptive humoral immune responses in children with shigellosis compared with in adults","volume":"55","author":"Raqib","year":"2002","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2018.12.067_b0175","doi-asserted-by":"crossref","first-page":"E4345","DOI":"10.1073\/pnas.1303641110","article-title":"Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation","volume":"110","author":"Paciello","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.12.067_b0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/mpat.2001.0443","article-title":"Analysis of the O-antigen chain length distribution during extracellular and intracellular growth of Shigella flexneri","volume":"31","author":"Varela","year":"2001","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2018.12.067_b0185","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.12.067_b0190","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.12.067_b0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fimmu.2011.00077","article-title":"Exploiting human memory B cell heterogeneity for improved vaccine efficacy","volume":"2","author":"Pauli","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.12.067_b0200","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4049\/jimmunol.162.1.224","article-title":"The first dose of a Haemophilus influenzae type b conjugate vaccine reactivates memory B cells: evidence for extensive clonal selection, intraclonal affinity maturation, and multiple isotype switches to IgA2","volume":"162","author":"Hougs","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.12.067_b0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/00365549409011803","article-title":"Serum antibody titres to Shigella lipopolysaccharides and invasion plasmid antigens in healthy Costa Rican and Swedish women","volume":"26","author":"Achi","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.067_b0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/glia.20272","article-title":"Diverse microglial responses after intrahippocampal administration of lipopolysaccharide","volume":"53","author":"Herber","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.vaccine.2018.12.067_b0215","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","article-title":"Microglia in Alzheimer's disease","volume":"127","author":"Sarlus","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2018.12.067_b0220","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/jb.162.2.738-745.1985","article-title":"High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli","volume":"162","author":"Peterson","year":"1985","journal-title":"J Bacteriol"},{"issue":"7","key":"10.1016\/j.vaccine.2018.12.067_b0225","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/mrc.1260240712","article-title":"NMR studies of bile acid salts: 2D NMR studies of aqueous and methanolic solutions of sodium cholate and deoxycholate","volume":"24","author":"Campredon","year":"1986","journal-title":"Magn Reson Chem"},{"key":"10.1016\/j.vaccine.2018.12.067_b0230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2018.12.067_b0235","first-page":"656","article-title":"Spectrophotometric determination of total nucleic acids","volume":"23","author":"Spirin","year":"1958","journal-title":"Biokhimiia"},{"key":"10.1016\/j.vaccine.2018.12.067_b0240","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.12.067_b0245","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0003-2697(82)90593-0","article-title":"A highly sensitive periodic acid-silver stain for 1,2-diol groups of glycoproteins and polysaccharides in polyacrylamide gels","volume":"119","author":"Dubray","year":"1982","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2018.12.067_b0250","unstructured":"Ph. Eur. Pyrogens (2.6.8.). European Pharmacopoeia 8-th Edition. July; 2013:183\u201384."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:30:00Z","timestamp":1759401000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19300489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0264410X19300489"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}